<DOC>
	<DOCNO>NCT01890655</DOCNO>
	<brief_summary>To evaluate long-term safety tolerability MT-1303 subject relapse remit multiple sclerosis ( RRMS ) .</brief_summary>
	<brief_title>Extension Study MT-1303</brief_title>
	<detailed_description />
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis , Relapsing-Remitting</mesh_term>
	<criteria>Completion 24week treatment period MT1303E04 per protocol Able provide write informed consent comply requirement protocol For male female reproductive potential , two method contraception must use throughout study 12 week cessation study medication . At least one method contraception must barrier method . Permanent discontinuation study medication prior end treatment ( EOT ) visit MT1303E04 Newly diagnose diabetes mellitus MT1303E04</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>relapsing-remitting multiple sclerosis</keyword>
	<keyword>RRMS</keyword>
</DOC>